Verification evidence is still being completed.
Bayer Pharmaceuticals
Leverkusen, Germany
- Verified lead
- Bill Anderson
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- Pharmaceutical Manufacturing and Therapeutic Platforms
- Review cycle
- May 2026
- Full address
- D-51368 Leverkusen, Germany
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Bayer leadership page confirming Bill Anderson as CEO.
- Editorial note
- Bayer joins the verified German core through its current leadership surface and live pharmaceutical operating overview.
Pharmaceutical Manufacturing and Therapeutic Platforms
GMP Manufacturing, Global Quality Management
Bayer joins the verified German core through its current leadership surface and live pharmaceutical operating overview.
Bayer Pharmaceuticals
Pharmaceutical Manufacturing and Therapeutic Platforms · Global commercial manufacturing
Verified 14 Mar 2026 · 3 sources
Bayer joins the verified German core through its current leadership surface and live pharmaceutical operating overview.
- Address
- D-51368 Leverkusen, Germany
- Website
- bayer.com
- Company page
- Lead
- Bill Anderson (verified ↗)
- Compliance
- GMP Manufacturing
- Last reviewed
- 14 Mar 2026 (3mo ago)
- Scale
- Global commercial manufacturing
- Capabilities
- Commercial Therapeutics Manufacturing · Analytical Quality Control · Process Development and Formulation
- Founded
- 1863
- Headcount
- 10000+
Bill Anderson
Chief Executive Officer
Official Bayer supplier-information PDF identifying Bayer AG in D-51368 Leverkusen.
Open sourceGlobal commercial manufacturing
Leverkusen, Germany. Pharmaceutical Manufacturing and Therapeutic Platforms. Review completed on 14 Mar 2026.
EMA, FDA, and global pharmaceutical oversight
GMP Manufacturing, Global Quality Management
Pharmaceutical Manufacturing and Therapeutic Platforms
Bayer joins the verified German core through its current leadership surface and live pharmaceutical operating overview.
Bayer joins the verified German core through its current leadership surface and live pharmaceutical operating overview.
Core capabilities
Primary declared technical activities and areas of operating focus.
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Declared infrastructure
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- VERIFIED ACTIVE 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Frequently asked questions
- Where is Bayer Pharmaceuticals located?
- Bayer Pharmaceuticals operates from D-51368 Leverkusen, Germany, Leverkusen, Germany.
- Who runs Bayer Pharmaceuticals?
- Bayer Pharmaceuticals is led by Bill Anderson, Chief Executive Officer. Verified 14 Mar 2026.
- What certifications does Bayer Pharmaceuticals hold?
- Bayer Pharmaceuticals is documented under GMP Manufacturing.
- What does Bayer Pharmaceuticals do?
- Bayer joins the verified German core through its current leadership surface and live pharmaceutical operating overview. Core capabilities: Commercial Therapeutics Manufacturing, Analytical Quality Control, Process Development and Formulation.
Related technical briefs
Briefs that name Leverkusen as a covered market or city.
